MedTrace Logo

Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects

NCT02273622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-03-24

No results posted yet for this study

Summary

Explore the detoxifying potential of hydroxytyrosol and its effects on Phase II enzyme expression (leading to xenobiotics detoxification in the liver).

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

hydroxytyrosol

Pilot study with 20 participants, each participant will alternately by the two arms of the study (hydroxytyrosol 5 mg and 20 mg) and control, during 6 weeks.

DIETARY_SUPPLEMENT

placebo

Sponsors & Collaborators

  • IMDEA Food

    lead OTHER

Principal Investigators

  • Francesco Visioli, Prof · IMDEA Food

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02273622 on ClinicalTrials.gov